Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Fundación de investigación HM
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoffmann-La Roche
Cellectar Biosciences, Inc.
Endeavor Biomedicines, Inc.
Emory University
Eli Lilly and Company
St. Jude Children's Research Hospital
Jazz Pharmaceuticals
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Milton S. Hershey Medical Center
Novartis
Valent Technologies, LLC
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Pfizer
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
University of Virginia
Istari Oncology, Inc.
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Masonic Cancer Center, University of Minnesota
Washington University School of Medicine
Y-mAbs Therapeutics
Children's Oncology Group
National Cancer Institute (NCI)
City of Hope Medical Center
Bristol-Myers Squibb
Wake Forest University Health Sciences
Wake Forest University Health Sciences
Oncurious NV
Barbara Ann Karmanos Cancer Institute
Case Comprehensive Cancer Center
Lumos Pharma
Emory University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Washington University School of Medicine
University of California, San Francisco